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Zearalenone is a xenoestrogenic mycotoxin produced by Fusarium species. High exposure 40 
with zearalenone induces reproductive disorders worldwide. Cyclodextrins are ring-shaped 41 
host molecules built up from glucose units. The apolar cavity of cyclodextrins can entrap so-42 
called guest molecules. The formation of highly stable host-guest type complexes with 43 
cyclodextrins can decrease the biological effect of the guest molecule. Therefore, 44 
cyclodextrins may be suitable to decrease the toxicity of some xenobiotics even after the 45 
exposure. In this study, the protective effect of beta-cyclodextrins against zearalenone-46 
induced toxicity was investigated in HeLa cells and zebrafish embryos. Fluorescence 47 
spectroscopic studies demonstrated the formation of stable complexes of zearalenone with 48 
sulfobutyl-, methyl-, and succinyl-methyl-substituted beta-cyclodextrins at pH 7.4 (K = 1.4-49 
4.7 × 104 L/mol). These chemically modified cyclodextrins considerably decreased or even 50 
abolished the zearalenone-induced loss of cell viability in HeLa cells and mortality in 51 
zebrafish embryos. Furthermore, the sublethal effects of zearalenone were also significantly 52 
alleviated by the co-treatment with beta-cyclodextrins. To test the estrogenic effect of the 53 
mycotoxin, a transgenic bioindicator zebrafish model (Tg(vtg1:mCherry)) was also applied. 54 
Our results suggest that the zearalenone-induced vitellogenin production is partly suppressed 55 
by the hepatotoxicity of zearalenone in zebrafish. This study demonstrates that the formation 56 
of stable zearalenone-cyclodextrin complexes can strongly decrease or even abolish the 57 
zearalenone-induced toxicity, both in vitro and in vivo. Therefore, cyclodextrins appear as 58 
promising new mycotoxin binders. 59 
 60 





1. Introduction 64 
Zearalenone (ZEN; Fig. 1) is a xenoestrogenic mycotoxin produced by Fusarium species, 65 
which is a contaminant in cereals (e.g., maize and wheat), spices, and in different beverages, 66 
e.g., milk and beer (Maragos, 2010; EFSA, 2017). Because of the high thermal stability and 67 
wide occurrence of ZEN, its removal from the food chain is difficult (Ryu et al., 1999). Based 68 
on cell and animal experiments, several adverse effects are attributed to ZEN, e.g., 69 
hepatotoxicity and genotoxicity (Zinedine et al., 2007; Cheraghi et al., 2015). Furthermore, 70 
ZEN can activate estrogen receptors in humans and animals, therefore, ZEN is an endocrine 71 
disruptor molecule which induces reproductive disorders (EFSA, 2017; Shier et al., 2001). 72 
ZEN is extensively metabolized in the body, during which reduced derivatives (zearalenols, 73 
zearalanone, and zearalanols) and glucuronic acid conjugates of ZEN and its reduced 74 
metabolites are produced (EFSA, 2017). Some of these metabolites (e.g., α-zearalenol and α-75 
zearalanol) bind with significantly higher affinity to the estrogen receptors (and consequently 76 
exert higher toxicity) than ZEN (Shier et al., 2001; Filannino et al., 2011). 77 
Cyclodextrins (CDs) are ring-shaped host molecules with a hydrophilic external part, which 78 
ensures excellent aqueous solubility, and an apolar internal cavity, which can accommodate 79 
lipophilic guest molecules (Szente and Szejtli, 1999; Szente et al., 2018). Therefore, they are 80 
frequently utilized by food, cosmetic, and pharmaceutical industries. The pharmaceutical 81 
application of beta-CDs is most common, due to their favorable cavity size for drugs (Challa 82 
et al., 2005). The native beta-CD (BCD) is often contained by orally administered drugs, 83 
however, its parenteral use is limited due to its nephrotoxicity and relatively low aqueous 84 
solubility of BCD (Jambhekar and Breen, 2016a). Methylated beta-CDs are absorbed from the 85 
gastrointestinal tract and cause nephrotoxic effects, therefore, they are not used neither orally 86 
nor parenterally (Jambhekar and Breen, 2016a). The sulfobutylated beta-CD is an excellent 87 
solubilizer without nephrotoxic adverse effect, thus, it is even suitable for parenteral 88 
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application (Jambhekar and Breen, 2016b). Generally, the pharmaceutical industry applies 89 
drug-CD complexes with low binding constants to increase the aqueous solubility, 90 
gastrointestinal absorption, and/or cellular uptake of drugs (Jambhekar and Breen, 2016a). 91 
However, formation of highly stable CD complexes can strongly decrease the 92 
pharmacological effect and tissue uptake of drugs and other xenobiotics (Schaller and Lewald, 93 
2016; Weiss-Errico et al., 2017). 94 
Native and chemically modified beta-CDs can form stable complexes with mycotoxins, 95 
including aflatoxins (Dall’asta et al., 2003), citrinin (Poór et al., 2016), ochratoxin A (Poór et 96 
al., 2015a), and ZEN/zearalenols (Poór et al., 2017). The interaction of ZEN with beta-CDs 97 
has been reported in previous studies, demonstrating that native and chemically modified 98 
beta-CDs form highly stable complexes with ZEN (K is in the 104-105 L/mol range) 99 
(Dall’Asta et al., 2008; Dall’Asta et al., 2009; Poór et al., 2015b). Among beta-CDs tested, 100 
ZEN formed the most stable complexes with methyl and sulfobutyl derivatives (Poór et al., 101 
2015b). 102 
A beta-CD bead polymer has been shown recently to effectively remove ZEN and zearalenols 103 
added to aqueous solutions and corn beer samples (Poór et al., 2018). Furthermore, BCD 104 
strongly alleviated the toxic effect of ZEN in HepG2 cells, probably by limiting toxin uptake 105 
by the cells, as a result of the formation of highly stable mycotoxin-CD complexes (Poór et 106 
al., 2015b). Based on these observations, we hypothesize that CDs may also be effective as in 107 
vivo binders of ZEN. 108 
There are numerous of endocrine disruptors in the environment, especially estrogenic 109 
xenobiotics. Sensitive biomonitor/bioindicator organisms are commonly applied to test 110 
xenoestrogenic effects. Among these biomonitoring organisms, several fish models, including 111 
zebrafish, exist (Chen et al., 2010; Fetter et al., 2014; Bakos et al., 2019). The main advantage 112 
of zebrafish as a biosensor is the transparent body of embryos and larvae; therefore, the 113 
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fluorescence signal of a reporter protein can be easily studied in vivo in the living animal 114 
(Strähle et al., 2012). Zebrafish embryo is widely used as a model in developmental 115 
toxicology tests (Braunbeck et al., 2005; Scholz et al., 2008) because the developing and 116 
transparent zebrafish can be assessed conveniently for lethality and developmental 117 
abnormalities from fertilization through larval stages. Furthermore, the development of 118 
zebrafish embryos is very similar to the embryogenesis in higher vertebrates (including 119 
humans); therefore, this species is highly suitable for the investigation of the fundamental 120 
processes underlying embryonic development (Nagel, 2002; Weight et al., 2011). In addition 121 
to animal protection, it is also favorable that the same individual fish can be studied 122 
throughout the treatment (Segner, 2009). In our experiments, we used a vitellogenin reporter 123 
transgenic zebrafish line, the Tg(vtg1:mCherry) (Bakos et al., 2019). 124 
In this study, we examined the hypothesis that beta-CDs can limit the toxic effects of ZEN, 125 
employing BCD and its chemically modified derivatives, namely sulfobutylated beta-126 
cyclodextrin (SbBCD), randomly methylated beta-cyclodextrin (RAMEB), succinyl-beta-127 
cyclodextrin (SucBCD), and succinyl-methyl-beta-cyclodextrin (SuRAMEB) (Fig. 1). The 128 
stability of ZEN-CD complexes was tested in a physiological buffer by fluorescence 129 
spectroscopy. In our previous study, the cytotoxic effects of ZEN in the absence and presence 130 
of CDs were examined on HepG2 cell line (Poór et al., 2015b). Because HepG2 liver cells 131 
may significantly biotransform ZEN. Therefore, in this study, the toxic actions of ZEN were 132 
examined in HeLa (cervical cancer) cell line, in the absence and presence of CDs. The 133 
cytotoxicity of ZEN and CDs were evaluated based on ATP levels/well. Furthermore, the 134 
acute toxicity of ZEN was also examined on zebrafish embryos, in the absence and presence 135 
of CDs. Our results demonstrate that CDs can strongly alleviate the ZEN-induced toxicity 136 





Fig. 1: Chemical structures of zearalenone and beta-cyclodextrins tested. 140 
 141 
2. Materials and Methods 142 
2.1. Reagents 143 
Zearalenone (ZEN), Dulbecco’s Modified Eagle Medium (DMEM), and fluorescamine 144 
(Fluram) were purchased from Sigma-Aldrich (St. Louis, MO, US). Cyclodextrins, including 145 
beta-cyclodextrin (BCD), sulfobutylated beta-cyclodextrin (SbBCD), randomly methylated 146 
beta-cyclodextrin (RAMEB), succinyl-beta-cyclodextrin (SucBCD), and succinyl-methyl-147 
beta-cyclodextrin (SuRAMEB) were provided by CycloLab Cyclodextrin Research and 148 
Development Laboratory, Ltd (Budapest, Hungary). Bioluminescent ATP Assay Kit CLSII 149 
(Roche; Basel, Switzerland), fetal bovine serum (Pan-Biotech; Aidenbach, Germany), and 150 
bovine serum albumin (Biosera; Nuaille, France) were used as received. 151 
 152 
2.2. Steady-state fluorescence spectroscopic studies 153 
Fluorescence spectroscopic measurements were performed using a Hitachi F-4500 fluorimeter 154 
(Tokyo, Japan). Increasing amounts of CDs (final concentrations: 0, 25, 50, 100, 250, and 500 155 
μM) were added to ZEN (2 μM), after which fluorescence emission spectra of ZEN and ZEN-156 
CD complexes were recorded (λex = 315 nm). To approximate extracellular physiological 157 
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conditions, experiments were carried out in phosphate-buffered saline (PBS, pH 7.4; 158 
containing 8.00 g/L NaCl, 0.20 g/L KCl, 1.81 g/L Na2HPO4 × 2H2O, and 0.24 g/L KH2PO4). 159 
Stock solution of ZEN (5000 μM) was prepared in 96 v/v(%) ethanol (Reanal; Budapest, 160 
Hungary). In fluorescence spectroscopic studies, the concentration of ethanol did not exceed 161 
0.04 v/v (%). Binding constants (K, unit: L/mol) of ZEN-CD complexes were determined 162 
employing the graphical application of the Benesi-Hildebrand equation, assuming 1:1 163 









 (1) 165 
where I0 and I are the fluorescence emission intensity of ZEN without and with CDs, 166 
respectively (λex = 315 nm, λem = 455 nm). [CD] denotes the molar concentration of CDs 167 
(unit: mol/L), A is a constant, and n is the number of binding sites. 168 
 169 
2.3. Cell experiments 170 
2.3.1. Cell culturing and treatment 171 
Cell experiments were performed on HeLa cervical cancer cell line (ATCC: CCL-2). The 172 
adherent cells were cultured in DMEM with high glucose (4500 mg/L) containing 10% fetal 173 
bovine serum, penicillin (100 U/mL), and streptomycin (100 μg/mL) in 75 cm2 sterile cell 174 
culture flasks in humidified atmosphere with 5% CO2 and at 37 °C. Cells were trypsinized 175 
and plated onto 96-well sterile plastic plates. Stock solution of ZEN (5000 μM) were prepared 176 
in 96 v/v(%) ethanol. In cell experiments, solvent controls were also applied; however, the 177 
final concentrations of ethanol did not exceed 1 v/v(%), which did not influence significantly 178 
the viability of HeLa cells. During the treatments, the culture medium was replaced with fresh 179 
one, containing the appropriate concentrations of ZEN (50 μM) and/or CDs (0.0-1.0 mM). 180 




2.3.2. Measurements of cellular ATP and total protein levels 183 
To test the effects of ZEN and CDs alone and in combinations on the viability of HeLa cells, 184 
intracellular ATP and total protein levels were quantified (based on luciferin-luciferase ATP 185 
and fluram protein assays, respectively) as described previously (Csepregi et al., 2018). 186 
 187 
2.3.3. Statistical analyses in cell experiments 188 
Means and standard error (± SEM) values were derived from at least three independent 189 
experiments. The data showed normal distribution based on the Shapiro-Wilk normality test 190 
(IBM SPSS Statistics, V21). Statistical evaluation was performed using one-way ANOVA 191 
test (IBM SPSS Statistics, V21). The level of significance was set at p < 0.05 and p < 0.01. 192 
 193 
2.4. Experiments on zebrafish embryos 194 
2.4.1. Characterization of the Tg(vtg1:mCherry) biomarker zebrafish line 195 
The zebrafish line used in these experiments is a vitellogenin reporter transgenic zebrafish 196 
line. Vitellogenin is a glycoprotein that is inducible by environmental estrogens. The 197 
transgene construct used for the development of Tg(vtg1:mCherry) carried a long (3.4 kbp) 198 
natural vitellogenin-1 promoter sequence with a high number of ERE (estrogen responsive 199 
element) sites. The mCherry reporter is only produced in the liver, similarly to endogenous 200 
vitellogenin. The sensitivity and usability of the embryos of the line have been tested on 201 
several estrogenic compounds (including ZEN) as well as on environmental samples (Bakos 202 
et al., 2019). 203 
 204 
2.4.2. Zebrafish maintenance and egg collection 205 
Laboratory-bred Tg(vtg1:mCherry) zebrafish strain was held in breeding groups of 30 females 206 
and 30 males at the Department of Aquaculture (Szent István University, Hungary) in a 207 
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Tecniplast ZebTEC recirculation system (Tecniplast S.p.a., Italy) at 25.5 ± 0.5 °C (system 208 
water: pH 7.0 ± 0.2, conductivity 550 ± 50 µS) and on a 14h:10 h light:dark cycle. The fish 209 
were fed twice a day with dry granulate food (Zebrafeed 400-600 µm, Sparos Lda., Portugal) 210 
supplemented with freshly hatched live Artemia salina once a day. The fish were placed in 211 
breeding tanks (Tecniplast S.p.a.) late in the afternoon before the day of the experiment and 212 
allowed to spawn by removing the dividing walls next morning. The collected eggs were 213 
incubated in system water with methylene blue (2 mL 0.1% methylene blue in 1 L system 214 
water) (25 ± 2 °C) in Petri dishes (diameter: 10 cm). After 24 h, coagulated and/or non-215 
fertilized eggs were assorted, and a part of the embryos were disinfected with bleaching 216 
method to keep the experiment sterile.  217 
 218 
2.4.3. Embryo bleaching 219 
Bleaching of embryos was necessary because some microorganisms can break down the CD 220 
ring to glucose units during long-term experiments in aqueous solution. System water was 221 
removed with a plastic pipette and embryos were bathed in a bleach solution (0.0035% 222 
sodium hypochlorite) for 5 min. Then, the bleach solution was removed, and Petri dishes were 223 
filled with sterilized E3 medium (5.0 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 0.33 224 
mM MgSO4 in 1 L sterilized deionized water) for 5 min. E3 medium was removed and dishes 225 
were filled with new E3 solutions under a sterile box.  226 
 227 
2.4.4. Determination of lethal concentration (LC) values of ZEN 228 
96 hpf (hours post-fertilization) Tg(vtg1:mCherry) embryos were placed in groups of five in 229 
24-well plates (JET Biofil; Guangzhou, China). E3 medium were removed then zebrafish 230 
embryos were treated (2 mL/well) with 0, 1, 2, 3, 4, 5, 6, and 7 mg/L (equal to 0-22 μM) 231 
ZEN, each treatment was performed in four replicates. ZEN was dissolved in methanol, the 232 
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final concentrations of the solvent did not exceed 0.4 v/v (%) during the treatments. Solvent 233 
controls were also tested: At the applied concentrations, methanol alone did not affect the 234 
viability of zebrafish embryos. The mortality was evaluated after 24 h exposure. 235 
 236 
2.4.5. Testing the effects of CDs on zebrafish embryos in the absence and presence of ZEN 237 
Three concentrations (0.25 mM, 0.5 mM, and 1 mM) of beta-CDs (BCD, SbBCD, RAMEB, 238 
and SuRAMEB) with and without ZEN (final concentration: 4.0 mg/L or 12.6 μM) were 239 
diluted in sterilized E3 medium. Mixtures were filtered with 0.2 µm syringe filters (VWR 240 
International Ltd., Hungary) to gain bacteriologically sterile solutions. ZEN control (with 241 
methanol solvent) was diluted in E3 medium to 4.0 mg/L (12.6 μM) final concentration. Each 242 
treatment were prepared with bleached and non-bleached larvae to test disinfection procedure.  243 
96 hpf transgenic larvae were transferred in groups of ten in sterile 6-well plates (JET Biofil, 244 
China), the experiment was performed in three replicates. Thereafter, E3 medium was 245 
removed, each well were filled with 10 mL of treatment solution and larvae were incubated at 246 
26°C (± 1°C) on 14 h:10 h light:dark cycle for 24 h in each treatment. 247 
 248 
2.4.6. Imaging and analysis 249 
Five-day old embryos were placed to petri dishes (diameter: 6 cm; JET Biofil; Guangzhou, 250 
China) from each group. Overplus solutions were removed with a plastic pipette and were 251 
filled with 2 mL of 0.02% MS-222 (Tricane-methane-sulfonate; from Sigma-Aldrich; St. 252 
Louis, MO, US) anesthetic solution. Special designed petri dishes (with two cube-shaped 253 
tape, diameter: 10 cm) were filled with 4% methyl-cellulose solution. Anaesthetized embryos 254 
were placed to methyl-cellulose, oriented to the left side, and pushed to the bottom of the 255 
cellulose solution with a cut ended Microloader pipette tip (Eppendorf; Hamburg, Germany). 256 
Bright field (exposure time: 6 msec, magnification: 30x and 60x), and fluorescent (mCherry 257 
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filter, exposure time: 2 sec, magnification: 60x) images of larvae were taken under a 258 
fluorescent stereomicroscope (Leica M205 FA fluorescent stereomicroscope, Leica DFC 259 
7000T camera, Leica Application Suite X, Leica Microsystems GmbH; Wetzlar, Germany). 260 
Signals in the red range of the RGB (Red, Green, Blue) color range was evaluated by ImageJ 261 
software (Schneider et al., 2012) based on the prepared fluorescent images. An elliptical area 262 
of the same size was selected on each image and moved to the area of the liver, then the signal 263 
strength and the size of the affected area were determined. The integrated density values were 264 
determined for each treatment. The results of ZEN treatments (ZEN and ZEN+CDs) were 265 
corrected with the integrated density values of test solutions without the mycotoxin. 266 
 267 
2.4.7. Statistical analyses in zebrafish experiments 268 
The concentration-lethality curve was fitted and LC values were calculated by non-linear 269 
regression. Integrated density data were checked for normality with Shapiro-Wilk normality 270 
test and non-compliance with the requirements of parametric methods was established. 271 
Statistical significance was evaluated employing Kruskal-Wallis analysis with Dunn's 272 
multiple comparisons test. Results were analyzed and plotted by GraphPad Prism 6.01 273 
(GraphPad Software; San Diego, CA, US). 274 
 275 
3. Results and Discussion 276 
3.1. Interaction of ZEN with beta-CDs in physiological buffer  277 
Whereas the complex formation of ZEN with some beta-CDs has been reported, the 278 
interaction of SucBCD and SuRAMEB with ZEN has not been tested. Furthermore, previous 279 
experiments did not try to approximate extracellular physiological conditions; therefore, our 280 
spectroscopic experiments were performed in PBS buffer (pH 7.4). Each tested CD induced a 281 
strong increase in the fluorescence of ZEN (which is the sign of complex formation), showing 282 
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the following order in the fluorescence enhancement: SuRAMEB > RAMEB > SbBCD > 283 
SucBCD > BCD (Fig. 2A). Our results are in agreement with the previously published 284 
studies, which also suggest that the chemical modifications of BCD strongly increase the 285 
fluorescence signal of ZEN (Dall’Asta et al., 2009; Poór et al., 2015b). Then, the binding 286 
constants of ZEN-CD complexes were determined employing the Benesi-Hildebrand equation 287 
(Eq. 1). As it is demonstrated in Fig. 2B, Benesi-Hildebrand plots showed excellent linearity 288 
with the 1:1 stoichiometry model, and suggesting the formation of stable mycotoxin-CD 289 
complexes. ZEN forms similarly stable complexes with SucBCD (K = 5.5 × 103 L/mol) than 290 
with BCD (K = 6.5 × 103 L/mol), while other chemically modified beta-CDs bound to ZEN 291 
with higher affinity. The most stable mycotoxin-CD complexes were formed with SuRAMEB 292 
(K = 4.7 × 104 L/mol) followed by RAMEB (K = 2.0 × 104 L/mol) and SbBCD (K = 1.4 × 104 293 
L/mol). Since succinyl substitution of BCD resulted in slightly less stable ZEN-CD 294 
complexes than BCD, we did not use SucBCD in the following experiments.  295 
Our results demonstrate that each beta-CDs tested form stable complexes with ZEN in PBS 296 
(pH 7.4). The binding constants of BCD, SbBCD, and RAMEB complexes were similar but 297 
slightly lower than those previously found in ammonium acetate buffer (0.05 M) at pH 5.0 298 
(Poór et al., 2015b). These findings indicate that methyl and sulfobutyl substitutions of BCD 299 
strongly increase the stability of ZEN-CD complexes (Dall’Asta et al., 2009; Poór et al., 300 
2015b). Despite succinyl derivative of BCD slightly decreased the stability of the complexes 301 
formed, the simultaneous presence of succinyl and methyl substituents in SuRAMEB resulted 302 
in higher binding constants compared to both BCD and RAMEB. Succinyl-methyl, methyl, 303 
and sulfobutyl substitutions of BCD led to the approximately 7.2-, 3.1-, and 2.2-fold increase 304 





Fig. 2: (A) Fluorescence emission intensity of ZEN (2 μM) in the absence and presence of 308 
increasing concentrations of CDs (0-500 μM) in PBS (pH 7.4). (B) Benesi-Hildebrand plots 309 
of ZEN-CD complexes (λex = 315 nm, λem = 455 nm). 310 
 311 
3.2. Effects of ZEN on HeLa cells in the absence and presence of beta-CDs 312 
To test the effects of CDs on the ZEN-induced cytotoxicity, HeLa cells were treated with 313 
ZEN and/or CDs. After 48 h incubation, cell viability was mainly evaluated based on the 314 
cellular ATP content/well. Quantitation of cellular ATP levels is a widely accepted method to 315 
determine cell viability. However, previous studies indicated that the ATP level alone may be 316 
a misleading parameter (Sali et al., 2016; Kőszegi et al., 2007; Hochachka and Mcclelland, 317 
1997; Andreoli and Mallett, 1997). Therefore, to confirm the results from ATP assay, total 318 
protein levels were also quantified. Changes of cellular ATP and total protein levels showed 319 
good correlation (Fig. 3). To produce a strong decrease in cell viability, ZEN was applied at 320 
50 μM concentration in these experiments. Our data are in good agreement with a previous 321 
study on HeLa cells which reported that the IC50 value of ZEN is approximately 60 µM (Ayed 322 
et al., 2011). However, a wide cytotoxic concentration range for ZEN has been found in other 323 
cell lines: 5-40 µM in Caco-2 (colorectal adenocarcinoma) cells and 31-157 µM in HL-60 324 
(human leukemia) cells (Rai et al., 2019). As Fig. 3 demonstrates, BCD failed to significantly 325 
alleviate the ZEN-induced toxicity (it caused only slight increases in ATP and total protein 326 
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levels); however, other CDs considerably decreased or even abolished the toxic effects of 327 
ZEN. In a concentration-dependent fashion, the co-treatment of ZEN-exposed cells with 328 
SbBCD, RAMEB, or SuRAMEB increased both ATP and total protein levels compared to the 329 
cells exposed to ZEN alone. Low CD concentrations (0.25 mM) were minimally effective 330 
(only the total protein level was increased significantly by SuRAMEB), while 0.5 mM 331 
concentrations of CDs induced spectacular elevation of cell viability. In addition, SbBCD, 332 
RAMEB, and SuRAMEB completely abolished the ZEN-induced loss of cell viability at the 333 
highest concentration (1 mM). 334 
Considering the high stability of ZEN-CD complexes as well as the previously reported 335 
protective effect of BCD against ZEN in HepG2 cells (Poór et al., 2015b), it was reasonable 336 
to hypothesize that some of these CDs may also effectively alleviate the ZEN-induced 337 
cytotoxicity in vivo. BCD failed to significantly affect cell viability even at 1 mM 338 
concentration in HeLa cells, although it strongly alleviated the toxic effects of ZEN in HepG2 339 
cells in a previous study (Poór et al., 2015b). However, chemically modified beta-CDs 340 
(SuRAMEB, RAMEB, and SbBCD) caused the significant decrease of ZEN-induced loss of 341 
cell viability. This can be explained by the higher binding affinity of the mycotoxin towards 342 
these CDs. In the cell medium, ZEN can form stable complexes with bovine serum albumin 343 
contained by the fetal bovine serum. In previous fluorescence spectroscopic studies, similar K 344 
values (6.0 × 104 and 2.6 × 104 L/mol) of ZEN-BSA complex have been reported (Faisal et 345 
al., 2018; Ma et al., 2018). Therefore, ZEN is likely present in the cell medium mainly in 346 
albumin-bound form. Because CDs can form similarly stable complexes with ZEN than with 347 
albumin (see in 3.1), CDs can further decrease the free fraction of ZEN in the cell medium, 348 
thus further decreasing the cellular uptake of the mycotoxin. 349 
Under the applied conditions, even the highest concentration (1 mM) of CDs (BCD, SbBCD, 350 
RAMEB, and SuRAMEB) did not affect significantly ATP and total protein levels (Fig. S1). 351 
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Based on previous studies, SbBCD is a less toxic while the methylated derivatives are less 352 
tolerable compared to the native BCD (Kiss et al., 2010; Jambhekar and Breen, 2016b). 353 
Furthermore, in vitro studies suggests that SuRAMEB is a less toxic derivative compared to 354 
RAMEB (Kiss et al., 2010). In previous cell experiments, alpha-, beta-, and gamma-CDs as 355 
well as their hydroxypropyl, methyl, and carboxymethyl derivatives did not induce significant 356 
toxicity at 1 mM or lower concentrations in HEK293T (human embryonic kidney), HeLa, and 357 





Fig. 3: Effects of ZEN (50 μM) on the cellular ATP (A) and total protein (B) levels in HeLa 361 
cells, in the absence and presence of CDs (0-1 mM) after 48 h incubation (compared to the 362 
control: *p < 0.05, **p < 0.01; compared to ZEN alone: #p < 0.05, ##p < 0.01). 363 
 364 
3.3. Effects of ZEN on zebrafish embryos in the absence and presence of beta-CDs 365 
To confirm our results indicating the protective effects of CDs in HeLa cell in vitro, their 366 
influence on the ZEN-induced toxicity was further examined in zebrafish embryos. As the 367 
first step, the toxicity indicators in the selected exposure window were determined. Therefore, 368 
the effect of ZEN on Tg(vtg1:mCherry) embryos was determined between 96-120 hpf. Fig. 369 
4A demonstrates the concentration-mortality curve of ZEN. LC values (Fig. 4B) were higher 370 
than in an earlier study using the same strain, in which 0.893 mg/L (or 2.81 µM; in this study: 371 
4.405 mg/L or 13.84 µM) and 0.335 mg/L (or 1.05 µM; in this study: 3.625 mg/L or 11.39 372 
µM) LC50 and LC10 values of ZEN were reported, respectively (Bakos et al., 2013). Since 373 
earlier studies suggest that the survival of fish embryos decreases with their age (Gellert and 374 
Heinrichsdorff, 2001), these differences likely resulted from the different length of exposure 375 
(96-120 vs. 1-120 h period). The LC25 concentration of ZEN (4.0 mg/L or 12.6 μM) was 376 
selected for the following experiments (Fig. 4A and B) because it did not induce marked 377 
mortality while its sublethal effects were significant. Mortality data observed in the presence 378 
of ZEN and/or CDs are listed in Fig. 4C. ZEN-induced mortality (26.67%) was consistent 379 
with the previous treatments (see in Fig. 4A and B), and the bleaching method did not affect 380 
the viability of larvae. The OECD guideline criteria for fish embryo test accepts a maximum 381 
of 10% lethality in the control groups (OECD236, 2013). Since the mortality of the control 382 
groups was 0%, it obviously fulfills this criteria. Under the applied circumstances, CDs (0.25-383 
1.0 mM) alone did not increase the mortality. Furthermore, the co-exposure of ZEN with beta-384 
CDs completely abolished the lethal effects of ZEN (except 0.25 mM BCD) (Fig. 4C), 385 
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suggesting the considerable protective effects of CDs vs. ZEN-induced toxicity. The weaker 386 
protective effect of BCD on ZEN-induced mortality is in agreement with the previous 387 
observation that BCD forms less stable complexes with ZEN compared to SuRAMEB, 388 
RAMEB, and SbBCD (see in 3.1), as well as it is also in accordance with the results of cell 389 
experiments (Fig. 3). Some previous studies also pointed out that CDs can decrease the toxic 390 
actions of several compounds, due to the formation of stable host-guest type complexes. BCD 391 
strongly decreased the LC50 values of 1-dodecyl-3-methylimidazolium tetrafluoroborate 392 
(Hodyna et al., 2016), 20(S)-Protopanaxadiol-20-O-D-glucopyranoside (Nam et al., 2017), 393 





Fig. 4: LC values and mortality data of Tg(vtg1:mCherry) zebrafish embryos (120 hpf). 397 
Concentration-mortality curve of ZEN (A); lethal concentration and the corresponding 398 
standard deviation (SD) values of ZEN with  (B); and mortality data of ZEN and CDs alone as 399 




Besides the lethal outcome, sublethal effects of beta-CDs were also studied on 120 hpf 402 
zebrafish embryos. In general, beta-CDs caused mild phenotypic lesions on the treated 403 
embryos, such as uninflated swim bladder and mild pericardial edema (Fig. 5). Furthermore, a 404 
slight upward curvature of the body axis can be observed as a result of BCD and SuRAMEB 405 
treatments (Fig. 5A), whereas moderately irregular edges of the dorsal and ventral fins were 406 
noticed only on BCD-treated embryos (Fig. 5B). Quantitative values of sublethal effects are 407 
demonstrated in Fig. 6C. In previous studies, the presence of 1% or lower concentrations of 408 
hydroxypropyl-beta-CD did not affect the development in zebrafish embryos and larvae 409 
(Maes et al., 2012), and even 3 mM concentration of methyl-beta-CD did not induce abnormal 410 
cytokinesis of zebrafish embryos (Feng et al., 2002). Our results also suggest that BCD, 411 






Fig. 5: Representative developmental defects in 120 hpf zebrafish embryos after 24 h 416 
treatment with beta-CDs. (A) An untreated control and embryos treated with 1 mM of BCD, 417 
SbBCD, RAMEB, and SuRAMEB. Pericardial edema and uninflated swim bladder appeared 418 
as a result of beta-CD treatments. Slight upward curvature of the body axis can be observed 419 
after BCD and SuRAMEB treatments. (B) Moderately irregular edges (marked with asterisks) 420 
of the dorsal fin are apparent in the BCD-treated embryo. Scale bar: 500 µm. 421 
 422 
Sublethal effects were also studied on 120 hpf embryos treated with ZEN in the absence and 423 
presence of beta-CDs (Fig. 6). The effects of ZEN on the development of zebrafish embryos 424 
have been reported. During the 72-h treatment of the embryos, ZEN caused pericardial 425 
edema, eye deformity, and concentration-dependent dorsal curvature of the body axis (heart 426 
and soul (has) phenotype), which is also characterized by other estrogenic substances (Bakos 427 
et al., 2013). The has phenotype can be observed in ZEN-treated (12.6 μM) embryos as well 428 
as after the co-exposure of ZEN with 0.25 mM BCD, SbBCD, or RAMEB (Fig. 6). However, 429 
this morphological alternation was no longer observed during the co-treatment of ZEN-430 
exposed embryos with higher concentrations (0.5 and 1.0 mM) of beta-CDs (Fig. 6B). 431 
Interestingly, the ZEN-induced formation of has phenotype was also eliminated by the co-432 
treatment of 0.25 mM SuRAMEB, which is in good agreement with our previous 433 
observations: (1) SuRAMEB forms the most stable complex with ZEN among the beta-CDs 434 
tested (see in section 3.1) and (2) SuRAMEB was the only CD which significantly increased 435 
the total protein levels in ZEN-treated HeLa cells even at 0.25 mM concentration (Fig. 3B). 436 
Another developmental effect of ZEN is the lack of the gap in the melanophore streak along 437 
the ventral side at the base of the caudal fin (Bakos et al., 2013). This phenotype is also 438 
typical for endocrine disruptors in zebrafish embryos treated between 0-72 hpf (Yang et al., 439 
2010; Georgescu et al., 2011). Less pigmentation disorder was observed only after ZEN 440 
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treatment (without CDs), and there was no complete closure of melanophores streak. This 441 
may be explained by the fact that experiments were started with 96 hpf embryos when the 442 
process of pigmentation was slowed down compared to the previous developmental stages, 443 
and the duration of the treatment was too short for complete closure. 444 
The co-treatment of ZEN with 0.5 and 1 mM BCD typically resulted in uninflated swim-445 
bladder, and some individuals exhibited mild pericardial edema. Fin disorder, which was 446 
specific to BCD-treated embryos, was not observed. The co-exposure of ZEN with 0.5 and 1 447 
mM SbBCD caused inflated swim bladder in most of the individuals (which appeared 448 
regularly only with this CD) and a slight pericardial edema was also noticed. Typical 449 
sublethal symptoms, as a result of the simultaneous treatment with ZEN and RAMEB (0.5 450 
and 1 mM), were uninflated swim bladder and pericardial edema. There was no similar 451 
abnormality with the has phenotype regarding ZEN-SuRAMEB co-treatments; however, a 452 
slight pericardial edema was observed in all treated embryos. Furthermore, the 0.25 and 0.5 453 
mM concentrations of SuRAMEB (in the presence of ZEN) led to a slight downward 454 
curvature of the body axis. During the ZEN-SuRAMEB co-exposures, the swim bladders of 455 
the embryos were not inflated until the end of the experiment. Based on the above-listed 456 





Fig. 6: Representative developmental defects in 120 hpf zebrafish embryos after 24 h 460 
treatment with ZEN (12.6 μM) in the absence and presence of beta-CDs. ZEN-exposed 461 
embryos as well as bleach and solvent controls are demonstrated in panel A, while embryos 462 
co-treated with ZEN and CDs are represented in panel B. CDs reduced the sublethal effects of 463 
ZEN, as it can be observed on the bright field images. Scale bar: 500 µm. (C) The mean 464 
appearance of representative developmental defects after ZEN and ZEN+CD exposure (%) 465 
(has: heart and soul phenotype; pe: pericardial edema; sb: inflected swim bladder; usb: 466 
uninflected swim bladder; cb: curvature of the body axis; fin: irregular edges of dorsal fin). 467 
As a result of ZEN treatment (without CDs), the has phenotype appeared in each zebrafish 468 




Transgenic bioindicator models for estrogenic effects are increasingly used in toxicological 471 
studies. In vivo models allow the investigation of complex processes in the organism. Several 472 
transgenic zebrafish lines are suitable for the investigation of estrogenic effects of test 473 
compounds, of which Tg(vtg1:mCherry) was used in our studies (Bakos et al., 2019). In these 474 
experiments, the effects of ZEN in the absence and presence of beta-CDs were examined on 475 
96 hpf-120 hpf zebrafish embryos. We investigated the potential appearance of fluorescence 476 
signal in the liver of fish (at the end of the exposure time), indicating the xenoestrogenic 477 
effect of ZEN. ZEN treatment induced the transgene to function, which is indicated by 478 
fluorescence signal in the liver (Fig. 7A and B). The weakest fluorescence signal was 479 
observed in the liver of ZEN-treated embryos (in the absence of CDs; Fig. 7A). In ZEN-BCD 480 
co-treated fish, the intensity of the fluorescence signal was almost the same than in the 481 
presence of ZEN alone (without CDs). Surprisingly, ZEN-SbBCD co-exposure caused a 482 
concentration-dependent increase in the fluorescent signal; while SuRAMEB induced the 483 
strongest elevation at its lowest concentration (0.25 mM), above which the fluorescence 484 
signal gradually decreased (Fig. 7B). Simultaneous treatment of ZEN-exposed cells with 485 
RAMEB led to the strong increase in the fluorescence (0.5 mM RAMEB produced the highest 486 
effect in this whole experiment), however, no clear concentration-dependence can be 487 
observed. In untreated control embryos, no fluorescent signal was visible (Fig. 7A). The 488 
integrated density values were in agreement with the differences in the fluorescence 489 
intensities (Fig. 7C). When the integrated density values of ZEN-CD co-treatments were 490 
compared to ZEN, no significant differences were observed in the presence of BCD, however, 491 
statistically significant changes were noticed in the presence of 0.5 and 1.0 mM 492 




The germ layers from which the liver of the zebrafish is formed start to develop 4 to 6 h after 495 
fertilization, hepatic budding starts at 24 h after fertilization, and the liver starts working after 496 
50 h (Villenueve et al., 2014). First, the left lobe of the liver is formed, where the endogenous 497 
vitellogenin (and the fluorescent reporter) is produced; then, after 96 h (96 hpf), the right lobe 498 
of the liver also appears (Ober et al., 2003; Tao and Peng, 2009). The final shape of the liver 499 
appears around day 5 (120 hpf), and becomes well-defined in a relatively large area, where 500 
the fluorescence signal can be easily detected with a stereomicroscope (Bakos et al., 2019). 501 
Therefore, the liver works during the 96-120 h exposure window for short-term treatments 502 
when Tg(vtg1:mCherry) embryo model is used to test estrogen effects (as it is also confirmed 503 
in the current study). There are large variations in the fluorescence intensities and the 504 
integrated density values within the treatments. Interestingly, ZEN-CD co-treatments induced 505 
stronger fluorescence signals compared to ZEN alone. The reason is likely the high individual 506 
sensitivity of the embryos to the treatment. The cells of the embryos (including their liver 507 
cells) can be damaged by higher concentrations of toxic substances (Bakos et al., 2013, 2019). 508 
In that case, the induction of vitellogenin production can be strongly decreased, thus lowering 509 
the fluorescence signal in ZEN-treated fish as compared to ZEN-CD co-treatment. This 510 
hypothesis is also supported by our observations that the stronger fluorescence signal of the 511 
reporter and the higher integrated density values (Fig. 7) are accompanied with the 512 
considerably lower mortality (Fig. 4) and the substantially weaker sublethal symptoms (Fig. 513 
6). Furthermore, Fig. 7D shows that both ZEN and ZEN+BCD treatments significantly altered 514 
the size, shape and color of the liver compared to the liver of untreated control embryos, 515 
suggesting the significant hepatotoxic effect of ZEN. In contrast, simultaneous treatment of 516 
embryos with ZEN and other CDs (SbBCD, RAMEB, SuRAMEB) resulted in much smaller 517 
hepatic lesions, confirming their hepatoprotective effects against ZEN. These observations are 518 
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in agreement with the integrated density values, where stronger fluorescent signal and higher 519 







Fig. 7: Fluorescence signals of the vitellogenin reporter and integrated density values in 523 
Tg(vtg1: mCherry) embryos (n = 30/treatment) as well as the changes in liver size and shape 524 
as a result of ZEN and ZEN+CD treatments. ZEN-treated (12.6 μM) embryos as well as 525 
bleach (bl.cont.) and solvent controls (s.cont.) are demonstrated in panel A, while embryos 526 
co-treated with ZEN and CDs are represented in panel B. Livers of the treated embryos are 527 
demonstrated in Bright Field (B.F.) and in fluorescent (Fluo.) images. (C) Integrated density 528 
values of ZEN-CD co-treatments were compared to ZEN (**p < 0.01, *** p < 0.001, **** p 529 
< 0.0001). Data represent that co-treatments of embryos with ZEN and beta-CDs cause higher 530 
fluorescence signal than ZEN alone. (D) The changes in the liver size and shape (marked with 531 
white line) are shown as the results of ZEN and ZEN+CD treatments (ZEN: 12.6 μM; CDs: 1 532 
mM). Integrated density values which were equal to or less than the untreated controls were 533 
excluded from the evaluation. 534 
 535 
In addition to the solubilizing effect of CDs, the low stability of CD complexes (K ≈ 102-103 536 
L/mol) may support the cellular uptake of guest molecules, whereas CD complexes with 537 
significantly higher stability may impair uptake (Redenti et al., 2001; Irie and Uekama, 1999; 538 
Poór et al., 2015b). Therefore, the stability of CD complexes strongly affect the field of their 539 
application. Furthermore, some CD derivatives have proved to be suitable in the treatment of 540 
endotoxin shock in animal studies, likely due to their interactions with lipopolysaccharides 541 
(Arima et al., 2005). Moreover, CDs are also applied in the human therapy: hydroxypropyl-542 
beta-CD is applied for the treatment of Niemann-Pick disease (Davidson et al., 2019) and 543 
Sugammadex (a chemically-modified gamma-CD derivative) terminates the muscle relaxant 544 
effect of rocuronium (Cada et al., 2016). These effects result from formation of highly stable 545 
complexes of hydroxypropyl-beta-CD and Sugammadex with cholesterol and rocuronium, 546 
respectively. In addition to these pharmaceutical applications, it is reasonable to hypothesize 547 
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that CD technology may suitable for development mycotoxin binders, which may counteract 548 
the toxic effects of mycotoxins even after exposure. Our results demonstrate that some beta-549 
CDs are promising as binders of ZEN. 550 
 551 
4. Conclusions 552 
In summary, the protective effects of native and chemically modified beta-CDs on ZEN-553 
induced toxicity were investigated in HeLa cells and in zebrafish embryos. The chemically 554 
modified beta-CDs that formed more stable complexes with ZEN had considerably stronger 555 
protective effect on HeLa cells and zebrafish embryos against the toxic consequences of ZEN-556 
exposure. Since beta-CDs strongly decreased or even abolished the ZEN-induced toxicity 557 
both in our in vitro and in vivo models, it is reasonable to hypothesize that CD technology 558 
may be suitable for the development of new ZEN binders. However, further in vivo studies are 559 
needed to confirm the suitability of CDs as protective agents against ZEN exposure. 560 
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